会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明专利
    • Vessel coupling device
    • 船舶联轴器
    • JP2011156377A
    • 2011-08-18
    • JP2011085115
    • 2011-04-07
    • Cordis Corpコーディス・コーポレイションCordis Corporation
    • BONSIGNORE CRAIG
    • A61B17/00A61B17/11A61F2/06A61M25/01
    • A61F2/064
    • PROBLEM TO BE SOLVED: To provide a device for coupling two vessels seamlessly. SOLUTION: The device includes: a main vessel 10; a bypass vessel 80; a coupling graft 70 disposed within the main vessel end and the bypass vessel end; a main vessel internal stent-anchor 116 and a bypass vessel internal stent-anchor 115 configured to exert an outward force to seal each vessel with the coupling graft; and an external anchor 142 to seal the main vessel end and the bypass vessel end around the coupling graft. The main vessel and the bypass vessel are held in fluid communication via the coupling graft. COPYRIGHT: (C)2011,JPO&INPIT
    • 要解决的问题:提供一种无缝连接两个容器的装置。 解决方案:该装置包括:主容器10; 旁路容器80; 设置在主容器端和旁路容器端内的联接移植物70; 主容器内部支架锚定件116和旁路容器内部支架锚定件115,其构造成施加向外的力以用联接移植物密封每个容器; 以及外部锚固件142,以密封联接移植物周围的主容器端部和旁路容器端部。 主容器和旁路容器通过联接移植物保持流体连通。 版权所有(C)2011,JPO&INPIT
    • 4. 发明专利
    • Electron beam sterilization of medical device with bioactive coating
    • 具有生物涂层的医疗设备的电子束灭菌
    • JP2011104369A
    • 2011-06-02
    • JP2010254523
    • 2010-11-15
    • Cordis Corpコーディス・コーポレイションCordis Corporation
    • FALOTICO ROBERTLI CHENGXUENGUYEN THAI MINHPARKER THEODORE LZHAO JONATHON Z
    • A61L2/08A61M37/00
    • B65B31/00A61L2/087A61L2202/21B65B55/00B65B55/16B65D81/266
    • PROBLEM TO BE SOLVED: To provide a method for single-step terminal sterilization process for bioactive heparin coatings on materials and biomaterials containing heparin used in medical devices, such as catheters, tissue engineering scaffolds, or drug delivery carrier materials. SOLUTION: The present invention may include a medical device or an implant that could benefit from improved antithrombotic and biocompatible heparin surfaces. Other relevant device examples may include heparin or a heparin derivative-coated stents for reducing clotting and restenosis, dental or ophthalmological implants. These materials may, in cases, include additional polymeric compositions, such as polyethyleneimine, dextran sulfate, or their modified forms. These polymers together with heparin coatings may be applied to other substrate of medical devices such as metal, ceramics, or biologically derived materials. COPYRIGHT: (C)2011,JPO&INPIT
    • 要解决的问题:提供一种用于医疗装置(例如导管,组织工程支架或药物递送载体材料)中含有肝素的材料和生物材料上的生物活性肝素涂层的一步终端灭菌方法。 解决方案:本发明可以包括可以从改进的抗血栓形成和生物相容性肝素表面中受益的医疗装置或植入物。 其它有关的装置实例可包括肝素或用于减少凝血和再狭窄的肝素衍生物涂层的支架,牙科或眼科植入物。 在这些情况下,这些材料可以包括另外的聚合物组合物,例如聚乙烯亚胺,硫酸葡聚糖或其改性形式。 这些聚合物与肝素涂层一起可以应用于诸如金属,陶瓷或生物衍生材料的医疗装置的其它基底。 版权所有(C)2011,JPO&INPIT
    • 5. 发明专利
    • Coating for medical device having anti-thrombotic conjugate
    • 具有抗凝血药物的医疗器械涂层
    • JP2011019918A
    • 2011-02-03
    • JP2010161311
    • 2010-07-16
    • Cordis Corpコーディス・コーポレイションCordis Corporation
    • ZHAO JONATHON ZFALOTICO ROBERT
    • A61L31/00
    • A61L31/16A61L31/10A61L31/148A61L33/0029C08L67/04
    • PROBLEM TO BE SOLVED: To provide a coating material for application to at least a portion of one surface of an article. SOLUTION: A method is provided for applying a coating comprising an anti-thrombotic agent and bioabsorbable polymer conjugate to at least some of an implantable device to prevent formation of thrombosis on the surface 10 of the device 50. A first or sub layer 20 of the coating is prepared by mixing polymeric material and a biologically active agent with a solvent, thereby forming a homogeneous solution. A second or outer layer 30 comprises an anti-thrombotic heparin 40-bioabsorbable polymer conjugate. This coating is applied in dip coating or spray coating processes. After drying, the anti-thrombotic heparin 40-bioabsorbable polymer conjugate remains in the outer layer of coating, allowing agent from the inner layer to elute therethrough. Also, the outermost layer prevents thrombosis, and modulates release kinetics of agent(s) contained within inner layer(s) of the coating. COPYRIGHT: (C)2011,JPO&INPIT
    • 要解决的问题:提供一种用于制品的一个表面的至少一部分的涂料。 解决方案:提供了一种用于将包含抗血栓形成剂和生物可吸收聚合物缀合物的涂层施用于至少一些可植入装置以防止在装置50的表面10上形成血栓形成的方法。第一或第二层 通过将聚合物材料和生物活性剂与溶剂混合制备涂层20,从而形成均匀的溶液。 第二层或外层30包含抗血栓形成肝素40-生物可吸收聚合物缀合物。 该涂层用于浸涂或喷涂工艺。 干燥后,抗血栓形成的肝素40-生物可吸收聚合物缀合物保留在涂层的外层中,允许来自内层的试剂从其中洗脱。 此外,最外层防止血栓形成,并且调节包被在内层内的药剂的释放动力学。 版权所有(C)2011,JPO&INPIT
    • 6. 发明专利
    • Adhesion promoting temporary mask for coated surfaces
    • 粘合促进涂层表面的临时掩模
    • JP2010148876A
    • 2010-07-08
    • JP2009290189
    • 2009-12-22
    • Cordis Corpコーディス・コーポレイションCordis Corporation
    • DAVE VIPULFALOTICO ROBERTLI CHENGXUENGUYEN THAI MPARKER THEODORE LZHAO JONATHON Z
    • A61L31/00A61F2/82A61L33/10
    • A61F2/91A61F2250/0068A61L31/10A61L31/16A61L33/0011A61L2300/00
    • PROBLEM TO BE SOLVED: To provide a heparin coated stent having reservoirs or openings therein. SOLUTION: An expandable medical device 10 includes a plurality of elongated struts 18, forming a substantially cylindrical device which is expandable from a first diameter to a second diameter. A plurality of different beneficial agents may be loaded into different openings 30a within the struts for delivery to the tissue. For treatment of conditions such as restenosis, different agents are loaded into different openings in the device to address different biological processes involved in restenosis and are delivered at different release kinetics matched to the biological process treated. The different agents may also be used to address different diseases from the same drug delivery device. In addition, anti-thrombotic agents may be affixed to at least a portion of the surfaces of the medical device for the prevention of sub-acute thrombosis. COPYRIGHT: (C)2010,JPO&INPIT
    • 要解决的问题:提供在其中具有储存器或开口的肝素涂层支架。 解决方案:可扩张医疗装置10包括多个细长支柱18,其形成从第一直径扩展到第二直径的基本上圆柱形的装置。 多个不同的有益剂可以被装载到支柱内的不同的开口30a中,以输送到组织。 为了治疗诸如再狭窄的病症,将不同的药剂装入装置中的不同开口以解决与再狭窄相关的不同生物过程,并且以与所治疗的生物过程相匹配的不同释放动力学递送。 不同的药剂也可用于解决来自同一药物递送装置的不同疾病。 此外,抗血栓形成剂可以附着在医疗装置的至少一部分表面上,以防止亚急性血栓形成。 版权所有(C)2010,JPO&INPIT
    • 7. 发明专利
    • Catheter system and method for filter retrieval
    • 导管系统和滤波器检索方法
    • JP2010104788A
    • 2010-05-13
    • JP2009249916
    • 2009-10-30
    • Cordis Corpコーディス・コーポレイションCordis Corporation
    • FLEMING JAMES A III
    • A61B17/50A61B17/00
    • PROBLEM TO BE SOLVED: To provide a filter catheter system for retrieving a previously implanted medical filter and a method of using the retrieval system. SOLUTION: This filter retrieval system 10 includes a flexible shaft 12, a retrieval element 14, and a handle 16 with an actuator 18. The flexible shaft which may be catheter-based, has a proximal and a distal end, with an opening near its distal end. The handle is affixed to the shaft near the proximal end of the shaft, and the actuator is adapted to manipulate the retrieval element. When an operator manipulates the actuator, the retrieval element is adapted to protrude slightly from the shaft opening. As the actuator is operated, the retrieval element can grasp or hook or otherwise engage a portion of the filter, and then pull the filter in through the opening into a lumen in a proximal or distal space defined by the flexible shaft. The retrieval system is capable of retrieving a filter like this. COPYRIGHT: (C)2010,JPO&INPIT
    • 要解决的问题:提供一种用于检索先前植入的医疗过滤器的过滤器导管系统和使用该检索系统的方法。 解决方案:该过滤器回收系统10包括柔性轴12,回收元件14和具有致动器18的手柄16.可以是基于导管的柔性轴具有近端和远端, 在其远端附近开放。 手柄固定在靠近轴的近端的轴上,并且致动器适于操纵检索元件。 当操作者操纵致动器时,取出元件适于从轴孔略微突出。 当致动器被操作时,回收元件可以抓住或钩住或以其他方式接合过滤器的一部分,然后将过滤器通过开口拉入到由柔性轴限定的近端或远端空间中的内腔中。 检索系统能够检索这样的过滤器。 版权所有(C)2010,JPO&INPIT
    • 9. 发明专利
    • Short term sustained drug-delivery system for implantable medical devices and method of making the same
    • 用于可植入医疗装置的短期持续的药物递送系统及其制造方法
    • JP2008264527A
    • 2008-11-06
    • JP2008082882
    • 2008-03-27
    • Cordis Corpコーディス・コーポレイションCordis Corporation
    • ZHAO JONATHON Z
    • A61F2/84A61L31/00
    • A61L31/16A61F2/91A61F2/915A61F2002/91558A61F2250/0068A61L2300/416A61L2300/602
    • PROBLEM TO BE SOLVED: To provide a short-term sustained drug eluting coating for implantable medical devices. SOLUTION: The coating comprises a biocompatible matrix and at least one pharmacologically or biologically active agent and releases substantially one of all of its payloads within four to six weeks post-implantation. When a combination of pharmacological agents are incorporated in the disclosed sustained drug eluting matrix of a drug/device combination, at least one agent is preferred to substantially release in a short duration. Medical devices benefiting from such a desired sustained drug eluting coating include drug eluting cardiovascular, peripheral, and neurovascular stents, abdominal aortic aneurysm prosthesis, anastomosis shunt, arterial/venous shunts etc. One embodiment of the invention is a sustained release coating or depot on or in a stent that releases substantially all of its payload for ischemic myocardial injury after a heart attack. COPYRIGHT: (C)2009,JPO&INPIT
    • 要解决的问题:提供用于可植入医疗器械的短期持续药物洗脱涂层。 解决方案:涂层包括生物相容性基质和至少一种药理学或生物活性剂,并且在植入后四至六周内释放其全部有效载荷中的其中一个。 当所公开的药物/装置组合的持续药物洗脱基质中并入药理学试剂的组合时,优选至少一种试剂在短时间内基本上释放。 受益于这种期望的持续药物洗脱涂层的医疗装置包括药物洗脱心血管,外周和神经血管支架,腹主动脉瘤假体,吻合分流,动脉/静脉分流等。本发明的一个实施方案是持续释放包衣或 在支架中,其在心脏病发作后基本上释放缺血性心肌损伤的所有有效载荷。 版权所有(C)2009,JPO&INPIT